COG5

Conserved oligomeric Golgi complex subunit 5 · Q9UP83 · COG5 on Sugi Atlas →

0 patent compounds predicted against COG5, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to COG5 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Safety and Efficacy of AAV9/AP4B1 (BFB-101) For Patients With AP4B1-related Hereditary Spastic Paraplegia Type 47 (SPG47) PHASE1/PHASE2NOT_YET_RECRUITING
Melpida: Recombinant Adeno-associated Virus (serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt) PHASE1/PHASE2RECRUITING
NEO100 and High-Grade Meningioma PHASE2RECRUITING
The Study of Quadruple Therapy Quercetin, Zinc, Metformin, and EGCG as Adjuvant Therapy for Early, Metastatic Breast Cancer and Triple-negative Breast Cancer, a Novel Mechanism EARLY_PHASE1UNKNOWN
Dynamics of Muscle Mitochondria in Type 2 Diabetes (DYNAMMO T2D) EARLY_PHASE1COMPLETED
Study of the Pathophysiological Mechanisms Involved in Bleeding Events nanCOMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM) nanCOMPLETED
MERC Proteins in Saliva and GCF in Periodontal Disease (ELISA Study) nanCOMPLETED
Natural History Study of GEMIN-5 Related Neurodevelopmental Disorder nanRECRUITING
Investigations Into ISCU Myopathy or Iron Sulfur Scaffold U Protein Myopathy nanCOMPLETED
Genetic Analysis of Gray Platelet Syndrome nanCOMPLETED
A Study on Risk Mutations of Vulnerability Genes of Schizophrenia nanUNKNOWN
Pediatric Evaluation and Registry for Liver Cholestasis in Canada nanRECRUITING
Study of Proteus Syndrome and Related Congenital Disorders nanRECRUITING
Immunological Profile and Clinical Characteristics of Children Diagnosed With Chronic Granulomatous Disease nanUNKNOWN
Hydroxychloroquin (HCQ) in chILD of Genetic Defect nanCOMPLETED
PET/CT Scans Using the Tracer 11C-Csar, a Bile Acid Analog, to Depict and Visualize Changes in the Hepatobiliary System in Patients With Primary Biliary Cholangitis Before and After Treatment. nanACTIVE_NOT_RECRUITING
Genetic Variations That Increase the Risk for Calcium Kidney Stones: a Family-based Study nanCOMPLETED
Identification of New FTLD Genes nanUNKNOWN
Genetic Characterization of Parkinson's Disease nanCOMPLETED
Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL) nanCOMPLETED
Dynamics of Muscle Mitochondria in Type 2 Diabetes Exercise nanCOMPLETED
Protein Synthesis in the Brain of Patients With Fragile X Syndrome nanCOMPLETED
Molecular Genetic Study of Schizophrenia: Parent-Offspring Trios nanCOMPLETED
Pathogenesis of Primary Ciliary Dyskinesia (PCD) Lung Disease nanRECRUITING
Open-Label Study of Omega 3 Oil Supplementation for Aging-Related Cognitive Decline nanCOMPLETED
Clinical, Cellular, and Molecular Investigation Into Oculocutaneous Albinism nanCOMPLETED
Investigating Phenotypic, Epigenetic, and NeuroGenetic Traits in Rare and Ultra-rare Neurodevelopmental Disorders (Project PENGUIN) nanRECRUITING
Biomarker Research in Inherited Movement Disorders nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a COG5 binder may also engage these)

ProteinNameSimilarity
Q8C0L8 1.000 Q8C0L8 →
F4JHH5 0.998 F4JHH5 →
Q6NMI3 0.998 Q6NMI3 →
Q9FGN0 0.997 Q9FGN0 →
COG7 Conserved oligomeric Golgi complex subunit 7 0.994 landscape →
F4HQ84 0.994 F4HQ84 →
F4JRR1 0.993 F4JRR1 →
O35250 0.993 O35250 →
Q9C9V9 0.992 Q9C9V9 →
Q3T1G7 0.992 Q3T1G7 →
Q9LXX6 0.991 Q9LXX6 →
Q9FFF3 0.991 Q9FFF3 →
O54922 0.990 O54922 →
Q29N70 0.990 Q29N70 →
Q8MSY4 0.990 Q8MSY4 →
Q19262 0.990 Q19262 →
Q1E6R9 0.990 Q1E6R9 →
E7FC72 0.990 E7FC72 →
P0DXK2 0.990 P0DXK2 →
Q95TN4 0.989 Q95TN4 →
COG2 Conserved oligomeric Golgi complex subunit 2 0.989 landscape →
A2VDR8 0.989 A2VDR8 →
Q5AZS0 0.989 Q5AZS0 →
Q9HE88 0.989 Q9HE88 →
Q8CI04 0.989 Q8CI04 →
Q16ZN9 0.989 Q16ZN9 →
Q9VNH6 0.989 Q9VNH6 →
Q0V8C2 0.988 Q0V8C2 →
Q8L838 0.988 Q8L838 →
Q0CSR3 0.988 Q0CSR3 →